Biotechnology

Puma Biotechnology Reports Third Quarter 2025 Financial Results - BioSpace

Vir Biotechnology’s Earnings Call: Achievements and Challenges - TipRanks

Sana Biotechnology Inc reports results for the quarter ended September 30 - Earnings Summary - TradingView

Vir Biotechnology (NASDAQ:VIR) Releases Quarterly Earnings Results, Misses Expectations By $0.47 EPS - MarketBeat

Why Anbio Biotechnology Class A Stocks Are Tumbling - TipRanks

Sana Biotechnology Q3 net loss narrows - MarketScreener

OFAB Nigeria Media Awards Celebrate Science Journalism, Spotlights Biotechnology’s Role In Food Security - Science Nigeria

BRIEF-Sana Biotechnology Q3 Operating Expenses USD 43.515 Million - TradingView

Sana Biotechnology Reports Third Quarter 2025 Financial Results and Business Updates - GlobeNewswire

Puma Biotechnology (NASDAQ: PBYI) lifts net income outlook to $27–$29M after results - Stock Titan

International Biotechnology beats benchmark with 0.7% NAV gain - MarketScreener

Nautilus Biotechnology aims to revolutionize biomedicine with proteome platform - Traders Union

Results analysis: International Biotechnology Trust - Nov 2025 | Investor - trustintelligence.co.uk

Positive Outlook for Vir Biotechnology: Buy Rating Driven by Promising Pipeline Developments and Strong Cash Position - TipRanks

Royal London lets Cambridge lab space to biotechnology business - BE News